Dihydropyridine calcium channel blockers: a rare and reversible cause of hepatotoxicity with cholestasis in a CAPD patient

被引：6
|
作者：
Basile, C [1 ]
Mascia, E
机构：
[1] Hosp Martina Franca, Nephrol Unit, Martina Franca, Italy
[2] Mil Hosp, Dept Surg, Taranto, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1999年 / 14卷 / 11期
关键词：
D O I：
10.1093/ndt/14.11.2776
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：2776 / 2777
页数：2
相关论文
共 50 条
  • [11] Dihydropyridine calcium channel blockers and peripheral side effects
    Sirker, A
    Missouris, CG
    MacGregor, GA
    JOURNAL OF HUMAN HYPERTENSION, 2001, 15 (10) : 745 - 746
  • [12] Life-threatening interaction of mibefradil and β-blockers with dihydropyridine calcium channel blockers
    Mullins, ME
    Horowitz, BZ
    Linden, DHJ
    Smith, GW
    Norton, RL
    Stump, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (02): : 157 - 158
  • [13] Anti-Atherosclerotic Potential of Dihydropyridine Calcium Channel Blockers
    Ishii, Norio
    Matsumura, Takeshi
    Shimoda, Seiya
    Araki, Eiichi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (08) : 693 - 704
  • [14] Clinical pharmacokinetics of the newer dihydropyridine calcium channel blockers in hypertension
    Israili, ZH
    NEW ADVANCES IN CARDIOVASCULAR PHYSIOLOGY AND PHARMACOLOGY, 1998, 1184 : 45 - 57
  • [15] SPECIFIC NEUROTROPIC EFFECTS OF DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS
    KOCH, HJ
    DINSE, HR
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1994, 16 (10): : 687 - 689
  • [16] Dihydropyridine calcium channel blockers in the elderly with diabetic nephropathy: Are they safe?
    Khitan, Zeid J.
    Tzamaloukas, Antonios H.
    Brodsky, Sergey
    Shapiro, Joseph I.
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (01): : 203 - 204
  • [17] An 11-year retrospective comparison of dihydropyridine and non-dihydropyridine calcium channel blockers
    Jang, David H.
    Spyres, Meghan B.
    Nelson, Lewis S.
    Hoffman, Robert S.
    CLINICAL TOXICOLOGY, 2012, 50 (07) : 640 - 640
  • [18] THE INTERACTION OF DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS WITH CALMODULIN AND CALMODULIN INHIBITORS
    THAYER, SA
    FAIRHURST, AS
    MOLECULAR PHARMACOLOGY, 1983, 24 (01) : 6 - 9
  • [19] Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
    Mendez, Sean R.
    Frank, Rachel C.
    Stevenson, Elizabeth K.
    Chung, Mabel
    Silverman, Michael G.
    CHEST, 2021, 160 (01) : 89 - 93
  • [20] Separation of five dihydropyridine calcium channel blockers by micellar electrokinetic chromatography
    Wang, J
    Chen, HF
    Zhao, LF
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 1999, 27 (01) : 82 - 84
12345